Advances and Challenges in the Treatment of Skin Diseases with the Transdermal Drug Delivery System

    August 2023 in “ Pharmaceutics
    Tingting Cheng, Zongguang Tai, Min Shen, Ying Liu, Jiahui Yu, Jiandong Wang, Quangang Zhu, Zhongjian Chen
    Image
    Studysummary This paper reviews the development of transdermal drug delivery systems for skin diseases, from first to fourth generation, and highlights ongoing challenges and the importance of clinical trials, but provides no new clinical results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document "Advance and Challenges in the Treatment of Skin Diseases with the Transdermal Drug Delivery System" discusses the evolution, benefits, and challenges of the Transdermal Drug Delivery System (TDDS) in treating skin diseases. The TDDS has evolved from first-generation patches to fourth-generation nanocarriers, improving drug penetration into deeper skin layers. Various techniques like iontophoresis, prodrugs, chemical penetration enhancers, ultrasound, electroporation, and microneedles have been used to enhance drug delivery. The document also discusses the use of lipid vesicular carriers, lipid nanoparticles, emulsion-based carriers, and polymeric nanoparticles in treatment. Despite its potential, TDDS faces challenges like skin atrophy, cytotoxicity, phototoxicity, high costs, complex manufacturing conditions, and lack of standardized evaluation methods. More clinical trials are needed to confirm the efficacy and safety of TDDS.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results